Yahoo Malaysia Web Search

Sign In

Search results

  1. www.sandoz.comSandoz

    <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PVQMF29&gtm_auth=&gtm_preview=&gtm_cookies_win=x" height="0" width="0" style="display:none;visibility ...

  2. www.doctoroncall.com.my › medicine › enSandoz Sildegra 100mg Tablet 4s - DoctorOnCall

    Sandoz Sildegra 100mg Tablet is a prescription medicine which belongs to a group of medicines known as phosphodiesterase type 5 (PDE 5) inhibitors. Sandoz Sildegra 100mg Tablet can be taken with an empty stomach or with a meal.

  3. www.doctoroncall.com.my › medicine › enSandoz Acetylcysteine 600mg Tablet 2s (strip) - DoctorOnCall

    Aug 18, 2021 · Sandoz Acetylcysteine 600mg Tablet is a mucolytic agent, effective in clearing up mucus in respiratory conditions such as cystic fibrosis. Similar Products Fluimucil A 200mg For Oral Solution

  4. www.doctoroncall.com.my › medicine › enSandoz Amlibon 5mg Tablet 10s (strip) - DoctorOnCall

    Product Overview. Introduction of Sandoz Amlibon 5mg Tablet 10s (strip) Amlibon 5mg Tablet may be used alone or in combination with other medications. The dosage is determined by the reason for your prescription and the severity of your illness.

  5. en.wikipedia.org › wiki › SandozSandoz - Wikipedia

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] . Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.

  6. www.novartis.com › news › media-releasesSandoz receives FDA approval for Tyruko® (natalizumab-sztn ... -...

    Aug 25, 2023 · Basel, August 25, 2023 – Sandoz, a global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has approved its biosimilar Tyruko ® (natalizumab-sztn), developed by Polpharma Biologics.

  7. www.novartis.com › news › media-releasesSandoz receives US FDA approval for biosimilar Hyrimoz ... -...

    Mar 21, 2023 · Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®*. With this approval, Sandoz adalimumab HCF biosimilar will offer US patients reduced injection volume in citrate-free formulation.

  8. www.novartis.com › news › media-releasesSandoz to launch Hyrimoz® (adalimumab-adaz) high ... - Novartis

    Jul 1, 2023 · Basel, July 1, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that the citrate-free high-concentration formulation (HCF) of its biosimilar Hyrimoz ® (adalimumab-adaz) injection will be available in the United States starting July 1.

  9. www.globenewswire.com › news-release › 2024/03/05Sandoz receives FDA approval for first and only denosumab -...

    Mar 5, 2024 · Basel, March 5, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost ® (denosumab-bbdz) and Jubbonti...

  10. www.us.sandoz.com › our-work › what-we-doSandoz US

    Learn how Sandoz US, a global leader in generic and biosimilar medicines, works to improve and extend people's lives with high-quality and affordable products.